SURPASS-2 showed superiority over semaglutide 1 mg: HbA1c -2.46% vs -1.86%, weight -12.4 kg vs -6.2 kg at 40 weeks SURMOUNT (obesity): SURMOUNT-1 demonstrated 20.9% mean weight loss at 72 weeks (15 mg)
Drug companies can choose the right chemicals, decide where to put their goods, and figure out how much they need to give when they know that these two peptide APIs work in different ways
Sweeteners: saccharin sodium, acesulfame-K, sucralose, sodium cyclamate
The tirzepatide-associated change in hsCRP was significantly mediated by combined effect of changes in body weight, AHI and SASHB, by change in body weight alone and by changes in OSA metrics AHI and SASHB (Fig
Use the smallest syringe that fits your dose
Low-income beneficiaries who have reduced cost-sharing can't use their subsidy for weight-loss drug prescriptions, so the copayment could be a financial barrier